Published July 20, 2022
| Version v1
Proposal
Open
Financial Effects of a Tumor Disease – Development and Validation of a Patient Reported Outcome Measure in Germany: Study Protocol
Creators
- 1. Methods in Empirical Social Research, Institute of Sociology, Faculty of Arts, Humanities and Social Science, Dresden University, 01062 Dresden, Germany
- 2. Department for Health Economics and Health Care Management, School of Public Health, Bielefeld University, Postfach 10 01 31, 33615 Bielefeld, Germany
- 3. Section of Translational Medical Ethics, Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany
- 4. Department of Internal Medicine II, Hematology and Internal Oncology, University Jena, Am Klinikum, 07747 Jena, Germany
Description
Financial toxicity as an individual consequence of a cancer diagnosis currently evolves to a clinically relevant patient-reported outcome, as several US studies showed that financial burden from cancer patients could impact the quality of life and mortality significantly. However, there is only limited data about financial burden on patients from universal healthcare countries and, in particular, Germany. One reason for this is the lack of a standardised and validated German-language survey instrument to measure financial toxicity precisely. This study aims to develop such an appropriate instrument.
Files
Study Protocol FIAT_zenodo.pdf
Files
(334.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:7df08a47c6859208a35536cd4c447bb4
|
334.2 kB | Preview Download |